Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Miguel Ruiz-López"'
Autor:
Alfonso M. Gañán-Calvo, Sergio Blanco-Trejo, Miguel Ruiz-López, Gustavo V. Guinea, Luis B. Modesto-López, José Pérez-Rigueiro
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract Among the different polymers (proteins, polysaccharides, etc.) that make up natural fibers, fibroin is a protein produced by silk spinning animals, which have developed an optimized system for the conversion of a highly concentrated solution
Externí odkaz:
https://doaj.org/article/9464c7f71f8843dd8c6332e841b875fc
Autor:
Jeremy Vicencio, Carlos Sánchez-Bolaños, Ismael Moreno-Sánchez, David Brena, Charles E. Vejnar, Dmytro Kukhtar, Miguel Ruiz-López, Mariona Cots-Ponjoan, Alejandro Rubio, Natalia Rodrigo Melero, Jesús Crespo-Cuadrado, Carlo Carolis, Antonio J. Pérez-Pulido, Antonio J. Giráldez, Benjamin P. Kleinstiver, Julián Cerón, Miguel A. Moreno-Mateos
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-13 (2022)
PAM requirement is a constraint for genome editing but this has been circumvented by engineered Cas9 nucleases as SpG and SpRY recognizing minimal PAM sequences. Here, the authors validate and optimize SpG and SpRY in vivo expanding the targeting lan
Externí odkaz:
https://doaj.org/article/65af9233becc4657b1eecfc5e6d8262e
Autor:
Ana Belén Salamanca-Castro, Carolina Varela-Rodríguez, Marcelle Canto, Pilar Espallargas-Moya, Pedro Miguel Ruiz-López
BACKGROUND Traditional clinical effectiveness indicators provide a partial view of healthcare quality. The patient-reported outcomes measures (PROM) evaluate the psychological and social impact of the illnesses on the patient's daily activities. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9f0f4924dbc2afbad02781fd6ae5f6e
https://doi.org/10.2196/preprints.41623
https://doi.org/10.2196/preprints.41623
Autor:
null Pedro Salinas Hernández, null Rafael Trujillo Vilchez, null Antonio Arriví García-Ramos, null Rosana Grande Ladron de Guevara, null Angeles Rodríguez Jaraiz, null Pedro Gallurt Moreira, null Jose Maria Vieitez de Prado, null Miguel Ruiz López de Tejada, null Antonio Irigoyen Medina, null Juan Manuel Campos Cervera, null Juan Carlos Cámara Vicario, null Uriel Bohn Sarmiento, null Pedro López Tendero, null Juan Domingo Alonso Lajara, null Ana León Carbonero, null Marisa García de Paredes, null Juan de Alvaro Liaño, null Asunción Juarez Marroquí, null Luis López Gómez, null Diego Soto de Prado Otero
Publikováno v:
Journal of Analytical Oncology. 2
Background: This observational study evaluated the efficacy and safety of treatment with bevacizumab plus chemotherapy until disease progression (PD) in Spanish patients with metastatic colorectal cancer (mCRC). Methods: This multicentre, retrospecti